Our Unique Approach
Selonterra develops therapeutics for Alzheimer's disease and Parkinson's disease based on our breakthrough, novel mechanisms on genetics and gene regulatory networks.
Genetics plays a key role in AD and PD. In most cases there is no clear functional link between disease-associated gene variants and disease hallmarks. Consequently, the extensive body of information on disease-associated genes has not translated to therapeutics.
Selonterra's scientists integrate human genetics, molecular pathway analyses and gene regulation to identify disease-causing mechanisms and molecular targets, and exploit these to discover effective therepeutics.
Selonterra's scientists discovered unexpected gene regulatory functions for key Alzheimer's and Parkinson's genes.
Selonterra
